glp 1 ai AI: GLP-1 Coach Allurion launches AllurionMeds first AI-native

1 reducing the dosage for an additional 1-2 weeks before considering an increase again

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy, claiming the drugs are too complex to safely replicate.

This is EXACTLY why getting on a GLP-1 has been such a game changer for me and using Effecty made the whole process stupid easy

The molecular mechanisms of the neuroprotective effects of GLP-1 RA in diabetes-related degenerative diseases, including AD and PD, and their potential effects.

Los investigadores observaron mejoras potenciales en la regulacin del aumento de peso y los marcadores metablicos en comparacin con los grupos de control